Literature DB >> 16002455

Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry.

Rosamonde E Banks1, Anthea J Stanley, David A Cairns, Jennifer H Barrett, Paul Clarke, Douglas Thompson, Peter J Selby.   

Abstract

BACKGROUND: Profiling approaches in proteomics, such as surface-enhanced laser desorption/ionization (SELDI) mass spectrometry, are used in disease marker discovery. The aim of this study was to investigate the potential influence of selected preanalytical factors on the results obtained.
METHODS: Plasma samples anticoagulated with EDTA, citrate, or heparin, and serum samples from healthy volunteers were profiled by SELDI on CM10, immobilized metal affinity capture (IMAC) array with copper, and H50 chip surfaces. Using linear mixed-effects models, we examined the influence of elapsed time between venipuncture and sample separation (immediate to 24 h) and the type of serum tube used (Greiner Vacuette activator, gel serum separator, or plain tubes). We analyzed purified platelets, as well as platelet-poor and platelet-rich plasma samples treated with calcium and/or thrombin to determine the platelet contribution, directly or via the clotting process, to the profiles generated. We then used cluster analysis to identify samples with similar peak profiles.
RESULTS: Different plasma types and sera could be distinguished on the basis of cluster analyses of their spectral profiles. Elapsed time between venipuncture and separation of plasma and serum from blood samples altered the profiles obtained, particularly for serum samples and particularly on IMAC chips. The type of serum collection tube also affected the profiles because of differences in clotting time. In vitro manipulation of platelets revealed that specific peaks in IMAC profiles of serum appeared to be derived directly from platelets. Several other peaks, including some of those exhibiting time-dependent changes, arose during the clotting process.
CONCLUSION: Preanalytical variables, such as sample handling, can markedly influence results.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16002455     DOI: 10.1373/clinchem.2005.051417

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  45 in total

1.  SELDI-TOF derived serum biomarkers failed to differentiate between patients with beryllium sensitisation and patients with chronic beryllium disease.

Authors:  B C Tooker; R P Bowler; J M Orcutt; L A Maier; H M Christensen; L S Newman
Journal:  Occup Environ Med       Date:  2011-01-27       Impact factor: 4.402

Review 2.  Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer.

Authors:  Vathany Kulasingam; Maria P Pavlou; Eleftherios P Diamandis
Journal:  Nat Rev Cancer       Date:  2010-04-12       Impact factor: 60.716

Review 3.  Proteomic approaches to dissect platelet function: Half the story.

Authors:  Dmitri V Gnatenko; Peter L Perrotta; Wadie F Bahou
Journal:  Blood       Date:  2006-08-22       Impact factor: 22.113

4.  Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time.

Authors:  Bert Dhondt; Elise De Bleser; Tom Claeys; Sarah Buelens; Nicolaas Lumen; Jo Vandesompele; Anneleen Beckers; Valerie Fonteyne; Kim Van der Eecken; Aurélie De Bruycker; Jérôme Paul; Pierre Gramme; Piet Ost
Journal:  World J Urol       Date:  2018-12-21       Impact factor: 4.226

5.  Biobanking and international interoperability: samples.

Authors:  Michael Kiehntopf; Michael Krawczak
Journal:  Hum Genet       Date:  2011-07-15       Impact factor: 4.132

6.  Distinct plasma profile of polar neutral amino acids, leucine, and glutamate in children with Autism Spectrum Disorders.

Authors:  Rabindra Tirouvanziam; Tetyana V Obukhanych; Julie Laval; Pavel A Aronov; Robin Libove; Arpita Goswami Banerjee; Karen J Parker; Ruth O'Hara; Leonard A Herzenberg; Leonore A Herzenberg; Antonio Y Hardan
Journal:  J Autism Dev Disord       Date:  2012-05

Review 7.  Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.

Authors:  Muriel De Bock; Dominique de Seny; Marie-Alice Meuwis; Jean-Paul Chapelle; Edouard Louis; Michel Malaise; Marie-Paule Merville; Marianne Fillet
Journal:  J Biomed Biotechnol       Date:  2009-12-06

8.  Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias.

Authors:  Dale McLerran; William E Grizzle; Ziding Feng; William L Bigbee; Lionel L Banez; Lisa H Cazares; Daniel W Chan; Jose Diaz; Elzbieta Izbicka; Jacob Kagan; David E Malehorn; Gunjan Malik; Denise Oelschlager; Alan Partin; Timothy Randolph; Nicole Rosenzweig; Shiv Srivastava; Sudhir Srivastava; Ian M Thompson; Mark Thornquist; Dean Troyer; Yutaka Yasui; Zhen Zhang; Liu Zhu; O John Semmes
Journal:  Clin Chem       Date:  2007-11-02       Impact factor: 8.327

9.  Mesoporous silica chips for selective enrichment and stabilization of low molecular weight proteome.

Authors:  Ali Bouamrani; Ye Hu; Ennio Tasciotti; Li Li; Ciro Chiappini; Xuewu Liu; Mauro Ferrari
Journal:  Proteomics       Date:  2010-02       Impact factor: 3.984

10.  Optimizing sample handling for urinary proteomics.

Authors:  Richard S Lee; Flavio Monigatti; Andrew C Briscoe; Zachary Waldon; Michael R Freeman; Hanno Steen
Journal:  J Proteome Res       Date:  2008-07-29       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.